5 terminated, 2 completed, 1 active not recruiting, 1 recruiting. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 4, Completed 2, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
Follow TCD601: new trials by email Literature Review of TCD601 trials Research Report on TCD601
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant Siplizumab, Rabbit anti-thymocyte globulin - Renal Transplant Failure and Rejection | Phase 2 | Recruiting | Nefro Avillion Clinical Development, LLC | 120 | 2026-06-29 | 2026-10-06 |
| A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients TCD601 - ALS | Phase 1 | Terminated | ITB-Med LLC | 7 | 2024-04-16 | 2026-07-17 |
| A Study of TCD601 in de Novo Renal Transplant Recipients TCD601, belatacept, ATG - Renal Transplantation | Phase 2 | Completed | ITB-Med LLC | 76 | 2023-12-28 | 2026-05-05 |
| A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients TCD601, Placebo - Diabetes Mellitus, Type 1 | Phase 2 | Terminated | ITB-Med LLC | 9 | 2023-01-23 | 2025-08-14 |
| A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) TCD601 - Kidney Transplantation | Phase 2 | Terminated | ITB-Med LLC | 4 | 2023-01-17 | 2026-02-06 |
| A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) TCD601 - Kidney Transplantation | Phase 2 | Terminated | ITB-Med LLC | 7 | 2022-12-14 | 2026-07-13 |
| A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation TCD601, Cyclophosphamide, TAC - Liver Transplantation | Phase 2 | Active not recruiting | ITB-Med LLC | 12 | 2022-06-29 | 2024-11-27 |
| A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation TCD601, Tacrolimus (TAC), Corticosteroids (CS) - Kidney Transplantation | Phase 2 | Terminated | ITB-Med LLC | 33 | 2021-06-06 | 2026-03-12 |
| A Dose Escalation Study in de Novo Renal Transplantation TCD601, Tacrolimus (TAC), Corticosteroids (CS) - Kidney Transplantation | Phase 2 | Completed | ITB-Med LLC | 13 | 2021-05-26 | 2025-02-27 |
Amyotrophic Lateral Sclerosis (1) · Diabetes Mellitus, Type 1 (1) · Rejection, Psychology (1)
ITB-Med LLC (8) · Nefro Avillion Clinical Development, LLC (1)
United States (5) · Sweden (4) · Spain (3) · Austria (1) · Belgium (1) · Brazil (1) · Italy (1) · South Korea (1) · United Kingdom (1)
Fredrik Juhlin (3) · Tracy Killingsworth (2) · Fredrik Julin (1) · Kellie Kennon, BSN (1) · Nick Hryciw, MA (1)